COPD is a progressive respiratory condition characterised by airway obstruction, reduced lung function, and episodic symptom flare-ups. The disease affects an estimated 1.2 million people with a ...
Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 ...
Most patients with chronic obstructive pulmonary disease (COPD) remain untreated after diagnosis, leading to frequent exacerbations. After COPD diagnosis, prompt and effective single or dual ...
Appearing on BBC Morning Live, Dr Punam Krishan gave exact time people should have cough for before getting it checked ...
Many people with COPD can control their symptoms by using inhaled medicines each day. But inhaled medicines may not offer enough relief for people who also have high levels of a type of white blood ...
GSK is heading into the weekend with a win for its respiratory blockbuster Nucala—but for now, the details are slim. On Friday, GSK said that its IL-5 antibody Nucala plus inhaled maintenance therapy ...
Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The 2026 GOLD report newly highlights disease activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results